secwatch.observer — SEC 8-K summary
======================================

Issuer:     AMGEN INC (AMGN)
CIK:        0000318154
Form:       8-K
Filed at:   2022-11-03T23:59:59+00:00
Accession:  0000318154-22-000053
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Amgen Q3: GAAP EPS $3.98, non-GAAP $4.70; revenue $6.7B (-1%); volumes +8%; FY22 rev guide $26.0-26.3B
--------------------------------------------------------------------------------

- GAAP EPS $3.98 (up from $3.31); non-GAAP EPS $4.70 (up from $4.08).
- Total revenues $6.7B, down 1% YoY; product sales volumes grew 8%, offset by 5% lower net price and 2% FX headwind.
- Free cash flow $2.8B in Q3 versus $2.2B in prior year.
- FY 2022 revenue guidance revised to $26.0-26.3B; GAAP EPS $11.46-12.17; non-GAAP EPS $17.25-17.85.
- Non-GAAP policy changed: upfront license fees no longer excluded; Q3 2021 non-GAAP EPS recast downward by $0.59.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/318154/000031815422000053/0000318154-22-000053-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/318154/000031815422000053/amgn-20221103.htm
  HTML page:      https://secwatch.observer/filing/0000318154-22-000053

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer